Product Information

PROCHLORPERAZINE 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1057 per EA under NDC 68462088901. Its NADAC has been published 154 times since Dec 13, 2023.

FDA first approved this application on Mar 17, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PROCHLORPERAZINE 5 MG TABLET

PROCHLORPERAZINE MALEATE
$0.1057per EA

Strength

5 mg/1

NDC

68462088901

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

PROCHLORPERAZINE MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA216595

FDA Approved

3/17/2023

TE Code

AB

On Market Since

3/17/2023

Pharmacological Classes

Phenothiazine
Phenothiazines

Price Statistics

The NADAC for PROCHLORPERAZINE 5 MG TABLET has been published 154 times since Dec 13, 2023, and over the history we have for it it has declined 61.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1057 per EA
All-time high$0.2871 (Feb 14, 2024)
All-time low$0.1057 (Nov 18, 2026)
52-week high$0.1478
52-week low$0.1057
Median price$0.1519
Average price$0.1604
Largest weekly change+71.7% (Aug 21, 2024)
Weeks tracked154
Tracking sinceDec 13, 2023

Price History

1W

-5.2%

1M

-7.9%

3M

-10.3%

6M

-8.9%

1Y

-27.4%

3Y

N/A

5Y

N/A

All

-61.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PROCHLORPERAZINE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1057 per EA (NDC 68462088901), effective Nov 18, 2026.

How has the price of PROCHLORPERAZINE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for PROCHLORPERAZINE 5 MG TABLET has declined 61.5%. It has been tracked across 154 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 5 MG TABLET?

Since Dec 13, 2023, the NADAC for PROCHLORPERAZINE 5 MG TABLET has ranged from a low of $0.1057 (Nov 18, 2026) to a high of $0.2871 (Feb 14, 2024), with a median of $0.1519 per EA.

Are there cheaper alternatives to PROCHLORPERAZINE 5 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PROCHLORPERAZINE 5 MG TABLET?

PROCHLORPERAZINE 5 MG TABLET (NDC 68462088901) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.